Latest GlaxoSmithKline News

DeSantis blasts FDA for halting drugs ineffective on omicron

Jan. 25, 2022 16:57 PM EST

TALLAHASSEE, Fla. (AP) — Florida Gov. Ron DeSantis pushed Tuesday for coronavirus patients to continue receiving antibody treatments deemed ineffective against the omicron variant, vowing to fight White House health regulators in his latest feud with President Joe Biden. The...

Consumer goods giant Unilever cutting 1,500 management jobs

Jan. 25, 2022 08:43 AM EST

LONDON (AP) — Unilever, which makes Vaseline skin care products and Ben & Jerry’s ice cream, says it's laying off 1,500 staff as part of a company-wide restructuring. The proposed changes mean that senior management jobs will be cut by about 15% while junior management roles...

FDA halts use of antibody drugs that don't work vs. omicron

Jan. 24, 2022 17:49 PM EST

WASHINGTON (AP) — COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday. The Food and Drug Administration said it was...

Unilever won't top $68B bid for GSK consumer healthcare unit

Jan. 19, 2022 14:01 PM EST

LONDON (AP) — Unilever, the maker of Vaseline skin care products and Dove soap, says it won’t increase a 50 billion-pound ($68.2 billion) offer for GlaxoSmithKline’s consumer healthcare unit that was rejected last week. London-based GSK said Saturday that the bid...

GSK rejects $68b Unilever bid for consumer healthcare unit

Jan. 15, 2022 15:44 PM EST

LONDON (AP) — The pharmaceutical giant GlaxoSmithKline said Saturday it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit, a joint venture it controls in a partnership with Pfizer. The London-based company said in...

COVID-19 pill rollout stymied by shortages as omicron rages

Jan. 13, 2022 13:06 PM EST

WASHINGTON (AP) — Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. The problem, in part, is that production is still being...

EXPLAINER: New easy-to-use COVID-19 pills come with a catch

Dec. 26, 2021 09:27 AM EST

Newly infected COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear. The challenge is getting tested, getting a prescription and starting...

EXPLAINER: What COVID-19 therapies are available in US?

Dec. 24, 2021 09:34 AM EST

WASHINGTON (AP) — The U.S. recently added two new weapons to its small arsenal against the coronavirus: pills that patients can take at home to treat COVID-19. The drugs from Pfizer and Merck join a handful of other therapies that have been shown to blunt the worst effects of the...

Omicron may sideline two leading drugs against COVID-19

Dec. 19, 2021 12:29 PM EST

WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain. ...

New COVID-19 antibody drug OK'd to protect most vulnerable

Dec. 08, 2021 17:30 PM EST

WASHINGTON (AP) — Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination. Antibody drugs have been a standard treatment for treating COVID-19 infections...